Tertiary Nav - Press Releases Press ReleasesMedia Statements Press Releases Items Per Page 102550 News Category Business & FinancialCitizenshipEarningsMedia StatementProduct NewsRecognitionRegulatoryScience & Innovation Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Date Title 12/19/07 AVI BioPharma, Inc. Completes Registered Direct Offering, Raises $20.3 Million 12/13/07 AVI BioPharma, Inc. to Raise $20.3 Million in Registered Direct Offering 12/3/07 AVI BioPharma Receives Fast Track Designation for AVI-4658 for Treatment of Duchenne Muscular Dystrophy 11/16/07 AVI BioPharma Incorporated Third Quarter 2007 Results Conference Call Transcript 11/6/07 AVI BioPharma to Present on NEUGENE Countermeasures to Biological Threats at U.S. Department of Defense 2007 Biodefense Research Conference 11/6/07 AVI BioPharma Announces Third Quarter Financial Results 11/5/07 AVI BioPharma President and COO to Speak at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 11/1/07 AVI BioPharma Receives Orphan Drug Designation for AVI-4658 for Treatment of Duchenne Muscular Dystrophy 10/30/07 AVI BioPharma Announces 2007 Third Quarter Financial Results Conference Call 10/30/07 AVI BioPharma Announces Changes to Its Board of Directors Pagination First page « first Previous page ‹ previous … Page 70 Page 71 Page 72 Page 73 Current page 74 Page 75 Page 76 Page 77 Page 78 … Next page next › Last page last » Displaying 731 - 740 of 812 Toolkit Print Page | Email Alerts | RSS Feeds | Contacts
Press Releases Items Per Page 102550 News Category Business & FinancialCitizenshipEarningsMedia StatementProduct NewsRecognitionRegulatoryScience & Innovation Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Date Title 12/19/07 AVI BioPharma, Inc. Completes Registered Direct Offering, Raises $20.3 Million 12/13/07 AVI BioPharma, Inc. to Raise $20.3 Million in Registered Direct Offering 12/3/07 AVI BioPharma Receives Fast Track Designation for AVI-4658 for Treatment of Duchenne Muscular Dystrophy 11/16/07 AVI BioPharma Incorporated Third Quarter 2007 Results Conference Call Transcript 11/6/07 AVI BioPharma to Present on NEUGENE Countermeasures to Biological Threats at U.S. Department of Defense 2007 Biodefense Research Conference 11/6/07 AVI BioPharma Announces Third Quarter Financial Results 11/5/07 AVI BioPharma President and COO to Speak at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 11/1/07 AVI BioPharma Receives Orphan Drug Designation for AVI-4658 for Treatment of Duchenne Muscular Dystrophy 10/30/07 AVI BioPharma Announces 2007 Third Quarter Financial Results Conference Call 10/30/07 AVI BioPharma Announces Changes to Its Board of Directors Pagination First page « first Previous page ‹ previous … Page 70 Page 71 Page 72 Page 73 Current page 74 Page 75 Page 76 Page 77 Page 78 … Next page next › Last page last » Displaying 731 - 740 of 812